News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Altarac David
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Altarac David (Chief Medical Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 120,000 options to buy
@ $5.7, valued at
$684k
Granted 92 options to buy
@ $2.44, valued at
$225.2 |
|
| 01/19/2022 |
4
| Altarac David (Chief Medical Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 125,000 shares
@ $0 |
|
| 11/03/2021 |
4
| Altarac David (Chief Medical Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Paid exercise price by delivering 3,669 shares
@ $2.94, valued at
$10.8k
|
|
| 10/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2020 |
4
| Altarac David (Chief Medical Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.94, valued at
$247k
|
|
| 11/06/2019 |
4
| Altarac David (Chief Medical Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 120,000 options to buy
@ $5.7, valued at
$684k
|
|
| 11/06/2019 |
3
| Altarac David (Chief Medical Officer) has filed a Form 3 on Entasis Therapeutics Holdings Inc. |
|
|